MedTrace Logo

Study of the ETX-4143 2.0 Device in Subjects With Eye Pain

NCT06479382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-08-22

No results posted yet for this study

Summary

A prospective early-feasibility study to evaluate the safety and effectiveness of the ETX-4143 2.0 device. The device is intended to treat subjects with eye pain

Conditions

  • Eye Pain

Interventions

DEVICE

ETX-4143 2.0

Treatment of the eye with the ETX-4143 2.0 device

Sponsors & Collaborators

  • EyeCool Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Patrick R Casey, OD · VP of Clinical Develpment

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-11-29
Completion
2024-11-29

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479382 on ClinicalTrials.gov